Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/20/2015 01/21/2015 01/22/2015 01/23/2015 01/26/2015 Date
124.74(c) 125.085(c) 127.3(c) 125.57(c) 125.12(c) Last
1 102 897 1 196 838 1 579 283 977 026 1 203 838 Volume
+1.53% +0.28% +1.77% -1.36% -0.36% Change
More quotes
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs.The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Pharmaceuticals
Calendar
01/28Earnings Release
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 572 M
EBIT 2014 -664 M
Net income 2014 -707 M
Finance 2014 579 M
Yield 2014 -
Sales 2015 1 192 M
EBIT 2015 -127 M
Net income 2015 -247 M
Finance 2015 665 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 51,6x
EV / Sales 2015 24,7x
Capitalization 30 094 M
More Financials
Latest news on VERTEX PHARMACEUTICALS INC
01/14 VERTEX PHARMACEUTICALS : Announces Upcoming Presentation at the J.P. Morgan Heal..
01/11 VERTEX PHARMACEUTICALS : Pharma Expects 2015 Kalydeco Revenues Of $560 Mln To $5..
01/11 VERTEX PHARMACEUTICALS : Outlines 2015 Business Priorities
01/11 VERTEX PHARMACEUTICALS : Outlines 2015 Business Priorities to Support the Develo..
01/08 VERTEX PHARMACEUTICALS : Reports Summarize Magnetic Resonance Research Findings ..
01/08 VERTEX PHARMACEUTICALS : U.S. Food and Drug Administration Approves KALYDECO® iv..
01/08 VERTEX PHARMACEUTICALS : New Findings from Vertex Pharmaceuticals Inc. in the Ar..
01/08 VERTEX PHARMACEUTICALS : Investigators at Vertex Pharmaceuticals Inc. Discuss Fi..
More news
Sector news Biopharmaceuticals
07:21aDJIndia Shares Rise to New High
07:18a PFIZER : beats Street 4Q forecasts
07:02a PFIZER : Reports fourth-quarter and full-year 2014 results; provides 2015 financ..
Plus d'actualités du secteur Biopharmaceuticals


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF